Results 111 to 120 of about 387,880 (260)
Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa +3 more
wiley +1 more source
Meeting the challenge for foot health in rheumatic diseases
Background: National guidelines recommend that patients with rheumatic diseases should have access to podiatry services and evidenceis emerging that podiatry interventions are effective in the management of foot problems in this patient group.
Williams, AE, Bowden, AP
core +1 more source
The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort
Objective Cardiac involvement significantly impacts prognosis in systemic sclerosis (SSc), highlighting the need for early risk stratification. Gastrointestinal (GI) symptoms are common and often manifest early. Emerging data suggest a link between GI and cardiac manifestations, possibly through shared mechanisms like dysautonomia.
Francesca R. Di Ciommo +9 more
wiley +1 more source
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?
Objective The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet +11 more
wiley +1 more source
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Cardiovascular co-morbidity in rheumatic diseases.
Patients with rheumatic disorders have an increased risk of cardiovascular disease (CVD). This excess co-morbidity is not fully explained by traditional risk factors.
Jacobsson, Lennart +5 more
core
Introduction: Sjögren’s syndrome (SS) is an autoimmune disease characterized predominantly by exocrine gland inflammation, leading to xerostomia and/or xerophthalmia, along with systemic manifestations.
Shweta Nakarmi +3 more
doaj +1 more source
Anorectal Dysfunction in Systemic Sclerosis: Clinical Phenotypes and Functional Patterns
Objective The aim of this study was to characterize specific physiologic defects in anorectal dysfunction in systemic sclerosis (SSc) using anorectal manometry (ARM), evaluate associations with gastrointestinal (GI) and extraintestinal clinical phenotypes, and explore potential serologic markers for risk stratification.
Timothy Kaniecki +6 more
wiley +1 more source
Neuroendocrine immunology in rheumatic diseases
The compendium on Rheumatic Diseases found its origin in the successful EULAR on-line course on rheumatic diseases. The yearly updated reviews of the fifty modules of that course form the content of this book.
CUTOLO, MAURIZIO +2 more
core +1 more source
Hendra Gunawan,1 Risa Miliawati Nurul Hidayah,1 Kartika Ruchiatan,1 Miranti Pangastuti,1 Hermin Aminah Usman,2 Fatimah Amalia1 1Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran – Dr.
Gunawan H +5 more
doaj

